TY - JOUR AU - Farhood, B. AU - Najafi, M. AU - Mortezaee, K. PY - 2019 DA - 2019// TI - CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review JO - J Cell Physiol VL - 234 UR - https://doi.org/10.1002/jcp.27782 DO - 10.1002/jcp.27782 ID - Farhood2019 ER - TY - JOUR AU - Durgeau, A. AU - Virk, Y. AU - Corgnac, S. AU - Mami-Chouaib, F. PY - 2018 DA - 2018// TI - Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy JO - Front Immunol. VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00014 DO - 10.3389/fimmu.2018.00014 ID - Durgeau2018 ER - TY - JOUR AU - Wei, W. AU - Rosenkrans, Z. T. AU - Liu, J. AU - Huang, G. AU - Luo, Q. Y. AU - Cai, W. PY - 2020 DA - 2020// TI - ImmunoPET: concept, design, and applications JO - Chem Rev VL - 120 UR - https://doi.org/10.1021/acs.chemrev.9b00738 DO - 10.1021/acs.chemrev.9b00738 ID - Wei2020 ER - TY - JOUR AU - Wei, W. AU - Jiang, D. AU - Ehlerding, E. B. AU - Luo, Q. AU - Cai, W. PY - 2018 DA - 2018// TI - Noninvasive PET imaging of T cells JO - Trends Cancer. VL - 4 UR - https://doi.org/10.1016/j.trecan.2018.03.009 DO - 10.1016/j.trecan.2018.03.009 ID - Wei2018 ER - TY - JOUR AU - Wei, W. AU - Jiang, D. AU - Lee, H. J. PY - 2020 DA - 2020// TI - Development and characterization of CD54-targeted immunoPET imaging in solid tumors JO - Eur J Nucl Med Mol Imag. VL - 47 UR - https://doi.org/10.1007/s00259-020-04784-0 DO - 10.1007/s00259-020-04784-0 ID - Wei2020 ER - TY - JOUR AU - Wei, W. AU - Liu, Q. AU - Jiang, D. PY - 2020 DA - 2020// TI - Tissue factor-targeted immunoPET imaging and radioimmunotherapy of anaplastic thyroid cancer JO - Adv Sci VL - 7 UR - https://doi.org/10.1002/advs.201903595 DO - 10.1002/advs.201903595 ID - Wei2020 ER - TY - JOUR AU - Wei, W. AU - Jiang, D. AU - Ehlerding, E. B. PY - 2019 DA - 2019// TI - CD146-targeted multimodal image-guided photoimmunotherapy of melanoma JO - Adv Sci VL - 6 UR - https://doi.org/10.1002/advs.201801237 DO - 10.1002/advs.201801237 ID - Wei2019 ER - TY - JOUR AU - Wei, W. AU - Jiang, D. AU - Lee, H. J. PY - 2020 DA - 2020// TI - ImmunoPET imaging of TIM-3 in murine melanoma models JO - Adv Ther. VL - 3 UR - https://doi.org/10.1002/adtp.202000018 DO - 10.1002/adtp.202000018 ID - Wei2020 ER - TY - JOUR AU - Leun, A. M. AU - Thommen, D. S. PY - 2020 DA - 2020// TI - CD8(+) T cell states in human cancer: insights from single-cell analysis JO - Nat Rev Cancer VL - 20 UR - https://doi.org/10.1038/s41568-019-0235-4 DO - 10.1038/s41568-019-0235-4 ID - Leun2020 ER - TY - JOUR AU - Jansen, C. S. AU - Prokhnevska, N. AU - Master, V. A. PY - 2019 DA - 2019// TI - An intra-tumoral niche maintains and differentiates stem-like CD8 T cells JO - Nature VL - 576 UR - https://doi.org/10.1038/s41586-019-1836-5 DO - 10.1038/s41586-019-1836-5 ID - Jansen2019 ER - TY - JOUR AU - Kennedy, L. B. AU - Salama, A. K. S. PY - 2020 DA - 2020// TI - A review of cancer immunotherapy toxicity JO - Cancer J Clin. VL - 70 UR - https://doi.org/10.3322/caac.21596 DO - 10.3322/caac.21596 ID - Kennedy2020 ER - TY - JOUR AU - Kristensen, L. K. AU - Fröhlich, C. AU - Christensen, C. PY - 2019 DA - 2019// TI - CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models JO - Theranostics. VL - 9 UR - https://doi.org/10.7150/thno.37513 DO - 10.7150/thno.37513 ID - Kristensen2019 ER - TY - JOUR AU - Kristensen, L. K. AU - Christensen, C. AU - Alfsen, M. Z. AU - Cold, S. AU - Nielsen, C. H. AU - Kjaer, A. PY - 2020 DA - 2020// TI - Monitoring CD8a(+) T cell responses to radiotherapy and CTLA-4 blockade using [(64)Cu]NOTA-CD8a PET imaging JO - Mol Imag Biol VL - 22 UR - https://doi.org/10.1007/s11307-020-01481-0 DO - 10.1007/s11307-020-01481-0 ID - Kristensen2020 ER - TY - JOUR AU - Gill, H. AU - Seipert, R. AU - Carroll, V. M. PY - 2020 DA - 2020// TI - The production, quality control, and characterization of ZED8, a CD8-specific (89)Zr-labeled immuno-PET clinical imaging agent JO - AAPS J. VL - 22 UR - https://doi.org/10.1208/s12248-019-0392-0 DO - 10.1208/s12248-019-0392-0 ID - Gill2020 ER - TY - JOUR AU - Seo, J. W. AU - Tavaré, R. AU - Mahakian, L. M. PY - 2018 DA - 2018// TI - CD8(+) T-cell density imaging with (64)Cu-labeled Cys-Diabody informs immunotherapy protocols JO - Clin Cancer Res. VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-18-0261 DO - 10.1158/1078-0432.CCR-18-0261 ID - Seo2018 ER - TY - JOUR AU - Griessinger, C. M. AU - Olafsen, T. AU - Mascioni, A. PY - 2020 DA - 2020// TI - The PET-tracer 89Zr-Df-IAB22M2C enables monitoring of intratumoral CD8 T cell infiltrates in tumor-bearing humanized mice after T cell bispecific antibody treatment JO - Cancer Res VL - 80 UR - https://doi.org/10.1158/0008-5472.CAN-19-3269 DO - 10.1158/0008-5472.CAN-19-3269 ID - Griessinger2020 ER - TY - JOUR AU - Salvador, J. P. AU - Vilaplana, L. AU - Marco, M. P. PY - 2019 DA - 2019// TI - Nanobody: outstanding features for diagnostic and therapeutic applications JO - Anal Bioanal Chem VL - 411 UR - https://doi.org/10.1007/s00216-019-01633-4 DO - 10.1007/s00216-019-01633-4 ID - Salvador2019 ER - TY - JOUR AU - Lv, G. AU - Sun, X. AU - Qiu, L. PY - 2020 DA - 2020// TI - PET imaging of tumor PD-L1 expression with a highly specific nonblocking single-domain antibody JO - J Nucl Med. VL - 61 UR - https://doi.org/10.2967/jnumed.119.226712 DO - 10.2967/jnumed.119.226712 ID - Lv2020 ER - TY - JOUR AU - Hashimoto, M. AU - Kamphorst, A. O. AU - Im, S. J. PY - 2018 DA - 2018// TI - CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions JO - Annu Rev Med VL - 69 UR - https://doi.org/10.1146/annurev-med-012017-043208 DO - 10.1146/annurev-med-012017-043208 ID - Hashimoto2018 ER - TY - JOUR AU - Pagès, F. AU - Mlecnik, B. AU - Marliot, F. PY - 2018 DA - 2018// TI - International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30789-X DO - 10.1016/S0140-6736(18)30789-X ID - Pagès2018 ER - TY - JOUR AU - Galon, J. AU - Bruni, D. PY - 2019 DA - 2019// TI - Approaches to treat immune hot, altered and cold tumours with combination immunotherapies JO - Nat Rev VL - 18 ID - Galon2019 ER - TY - JOUR AU - Jreige, M. AU - Letovanec, I. AU - Chaba, K. PY - 2019 DA - 2019// TI - (18)F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer JO - Eur J Nucl Med Mol Imaging. VL - 46 UR - https://doi.org/10.1007/s00259-019-04348-x DO - 10.1007/s00259-019-04348-x ID - Jreige2019 ER - TY - JOUR AU - Togo, M. AU - Yokobori, T. AU - Shimizu, K. PY - 2020 DA - 2020// TI - Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma JO - Br J Cancer VL - 122 UR - https://doi.org/10.1038/s41416-020-0820-z DO - 10.1038/s41416-020-0820-z ID - Togo2020 ER - TY - JOUR AU - Rashidian, M. AU - Ingram, J. R. PY - 2017 DA - 2017// TI - Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells JO - J Exp Med VL - 214 UR - https://doi.org/10.1084/jem.20161950 DO - 10.1084/jem.20161950 ID - Rashidian2017 ER - TY - JOUR AU - Rashidian, M. AU - LaFleur, M. W. AU - Verschoor, V. L. PY - 2019 DA - 2019// TI - Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade JO - Proc Natl Acad Sci VL - 116 UR - https://doi.org/10.1073/pnas.1905005116 DO - 10.1073/pnas.1905005116 ID - Rashidian2019 ER - TY - JOUR AU - Pandit-Taskar, N. AU - Postow, M. A. AU - Hellmann, M. D. PY - 2020 DA - 2020// TI - First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.229781 DO - 10.2967/jnumed.119.229781 ID - Pandit-Taskar2020 ER -